Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1994 1
1997 1
1999 1
2001 1
2002 2
2003 2
2004 2
2005 1
2006 1
2007 1
2008 2
2009 5
2010 3
2011 3
2012 2
2013 6
2014 1
2015 4
2016 6
2017 3
2018 3
2019 4
2020 7
2021 8
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Enhancement pattern of demyelination-mimicking cerebral B-cell lymphoma.
Ma X, Guo Z, Huang Z, Hui D, Liu Y, Jiang Y, Lu Z, Qiu W, Lu T, Qin F. Ma X, et al. Eur J Neurol. 2022 Aug;29(8):2499-2504. doi: 10.1111/ene.15365. Epub 2022 May 4. Eur J Neurol. 2022. PMID: 35441750
METHODS: We retrospectively reviewed the brain MRI of biopsy-confirmed CNS B-cell lymphoma patients. They were initially diagnosed with CNS demyelination, and these images were compared with those of actual patients with demyelinating diseases. ...Enhancement in a s …
METHODS: We retrospectively reviewed the brain MRI of biopsy-confirmed CNS B-cell lymphoma patients. They were initially diagnosed with C …
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination.
Francis AG, Elhadd K, Camera V, Ferreira Dos Santos M, Rocchi C, Adib-Samii P, Athwal B, Attfield K, Barritt A, Craner M, Fisniku L, Iversen AKN, Leach O, Matthews L, Redmond I, O'Riordan J, Scalfari A, Tanasescu R, Wren D, Huda S, Leite MI, Fugger L, Palace J. Francis AG, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 21;10(1):e200063. doi: 10.1212/NXI.0000000000200063. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36411077 Free PMC article.
We described the features of patients presenting with new acute CNS demyelination resembling NMOSDs or MOGAD within 8 weeks of SARS-CoV-2 vaccination. ...Within the seronegative group, phenotypic differences were observed between ChAdOx1S and BNT162b2 recipie …
We described the features of patients presenting with new acute CNS demyelination resembling NMOSDs or MOGAD within 8 weeks of …
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases.
Bar-Or A, Hintzen RQ, Dale RC, Rostasy K, Brück W, Chitnis T. Bar-Or A, et al. Neurology. 2016 Aug 30;87(9 Suppl 2):S12-9. doi: 10.1212/WNL.0000000000002821. Neurology. 2016. PMID: 27572856 Review.
CSF analysis in pediatric-onset MS points to chronic CNS inflammation, supported by observations from limited pathologic material available for study. Emerging results implicate abnormalities in both effector and regulatory T cell subsets, and potentially immune senescence …
CSF analysis in pediatric-onset MS points to chronic CNS inflammation, supported by observations from limited pathologic material ava …
A systematic review of cases of CNS demyelination following COVID-19 vaccination.
Ismail II, Salama S. Ismail II, et al. J Neuroimmunol. 2022 Jan 15;362:577765. doi: 10.1016/j.jneuroim.2021.577765. Epub 2021 Nov 9. J Neuroimmunol. 2022. PMID: 34839149 Free PMC article.
OBJECTIVE: This study aims to systematically review the reported cases of CNS demyelination in association with COVID-19 vaccination, which has not been performed, to our knowledge. METHODS: A systematic review was performed by screening published articles and prepr …
OBJECTIVE: This study aims to systematically review the reported cases of CNS demyelination in association with COVID-19 vacci …
Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, Tosakulwong N, Parisi JE, Metz I, Frischer JM, Lassmann H, Brück W, Linbo L, Lucchinetti CF. Tobin WO, et al. Neurology. 2021 Nov 9;97(19):e1906-e1913. doi: 10.1212/WNL.0000000000012782. Epub 2021 Sep 9. Neurology. 2021. PMID: 34504026 Free PMC article.
METHODS: Immunopathologic subtyping was performed on specimens from 547 patients with biopsy- or autopsy-confirmed CNS demyelination. RESULTS: The frequency of immunopathologic subtypes was 23% for pattern I, 56% for pattern II, and 22% for pattern III. ...In additi …
METHODS: Immunopathologic subtyping was performed on specimens from 547 patients with biopsy- or autopsy-confirmed CNS demyelinati …
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
Simpson S Jr, Tan H, Otahal P, Taylor B, Ponsonby AL, Lucas RM, Blizzard L, Valery PC, Lechner-Scott J, Shaw C, Williams D; Ausimmune/AusLong Investigators Group; van der Mei I. Simpson S Jr, et al. Acta Neurol Scand. 2016 Dec;134(6):403-413. doi: 10.1111/ane.12554. Epub 2016 Jan 12. Acta Neurol Scand. 2016. PMID: 26756925
We evaluated the prevalence and factors associated with anxiety, depression and fatigue at the 5-year review of a longitudinal cohort study following a first clinical diagnosis of CNS demyelination (FCD). METHODS: Cases with a FCD were recruited soon after diagnosis …
We evaluated the prevalence and factors associated with anxiety, depression and fatigue at the 5-year review of a longitudinal cohort study …
Statins and their potential targets in multiple sclerosis therapy.
Stüve O, Prod'homme T, Slavin A, Youssef S, Dunn S, Steinman L, Zamvil SS. Stüve O, et al. Expert Opin Ther Targets. 2003 Oct;7(5):613-22. doi: 10.1517/14728222.7.5.613. Expert Opin Ther Targets. 2003. PMID: 14498824 Review.
While traditionally CNS autoantigen-specific CD4(+) T cells have been considered the culprits in the initial phase of the disease, recent observations have altered this concept. It is now recognised that other T lymphocyte subclasses can initiate CNS demyelinatio …
While traditionally CNS autoantigen-specific CD4(+) T cells have been considered the culprits in the initial phase of the disease, recent …
High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis.
Simpson-Yap S, Oddy WH, Taylor B, Lucas RM, Black LJ, Ponsonby AL, Blizzard L, van der Mei I; Ausimmune/AusLong Investigators Group. Simpson-Yap S, et al. Mult Scler. 2021 Jun;27(7):1112-1124. doi: 10.1177/1352458520943087. Epub 2020 Jul 23. Mult Scler. 2021. PMID: 32701031
RESULTS: In cases with a first clinical diagnosis of central nervous system (CNS) demyelination, we identified three major dietary patterns, 'Prudent', 'High-Vegetable' and 'Mixed', explaining 43%, 37% and 24% of diet variance in dietary intake, respectively. ...CON …
RESULTS: In cases with a first clinical diagnosis of central nervous system (CNS) demyelination, we identified three major die …
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
Ojha PT, Aglave VB, Soni G, Jagiasi KA, Singh RK, Singh RK, Nagendra S. Ojha PT, et al. Neurol India. 2020 Sep-Oct;68(5):1106-1114. doi: 10.4103/0028-3886.294831. Neurol India. 2020. PMID: 33109860 Free article.
OBJECTIVE: To characterize the clinico-radiologic spectrum and treatment outcomes of MOG antibody disease and differentiate it from aquaporin-4 (AQP-4) antibody positive neuromyelitis optica spectrum disorders (NMO-SD). METHODS: A single-center, observational study from We …
OBJECTIVE: To characterize the clinico-radiologic spectrum and treatment outcomes of MOG antibody disease and differentiate it from aquapori …
Therapy of multiple sclerosis in children and adolescents.
Tenembaum SN. Tenembaum SN. Clin Neurol Neurosurg. 2010 Sep;112(7):633-40. doi: 10.1016/j.clineuro.2010.04.015. Epub 2010 May 14. Clin Neurol Neurosurg. 2010. PMID: 20471159 Review.
The initial course of the disease is relapsing-remitting in most children, with a relapse rate generally higher than that observed in adult patients. There is published experience on the use of first-line disease modifying therapies in children with MS. ...CONCLUSION: The …
The initial course of the disease is relapsing-remitting in most children, with a relapse rate generally higher than that observed in …
71 results